Despite Wegovy coverage, Medicare patients may face high drug costs

Medicare has opened the door to Wegovy coverage for heart benefits, but analysts warn patients are still likely to face hurdles.

March 22, 2024 Check out STAT+

Sponsored By

Kayana Szymczak for STAT STAT+ | Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles Medicare opens door to Wegovy coverage for heart benefits, but analysts warn patients are still likely to face high costs and other hurdles. By Elaine Chen Abortion law emergency-exemption guidance proposed by Texas Medical Board The board drafted the rules after the state Supreme Court expressly called for such guidance in a decision that denied an emergency abortion. By Olivia Goldhill STAT+ | How biotech investors spot opportunity when stocks are down — and up Drug pricing and promising science shape the decisions of biotech industry investors looking for companies to support. By Allison DeAngelis and Mario Aguilar Tony Luong for STAT STAT+ | Hospitals turn to sports performance centers to offer athletes elite care — for the right price Hospitals tap into a growing market by moving beyond sports medicine to sports performance, using pro league ties and a self-pay model. By Elizabeth Cooney STAT+ | Opinion: Medical devices makers are trying to take a page from Uber's playbook Regulators and payers should be on the lookout for Uber-like behavior — including aggressive marketing strategies — on the part of device makers. By Kyle H. Sheetz and Robert M. Wachter STAT+ | Drug development was once a marathon. New tools and timelines are turning it into a sprint Leaders at Pfizer, Moderna, and FogPharma say mRNA and a new view of precision medicine have sped up biopharma drug development. By Elizabeth Cooney STAT Male birth control research wins audience over at STAT Madness event Current male birth control options are limited. Researchers are working on a new tack: a compound that stops sperm in its tracks. By Theresa Gaffney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser